Literature DB >> 26146592

Medical Histories: A Case Report of Pharmacovigilance in Supporting Dentists and Participation in a Drug-Safety Program.

Edward H Karl1, Frederick A Curro2.   

Abstract

INTRODUCTION: Antibiotics are a class of medications widely used by dentists. The class of agents has a number of listed side effects. This case report details an unusual adverse effect of tetracycline-induced psychosis recognized due to the diligence of a practitioner. To our knowledge, this is the first reported case by a dentist. CASE
PRESENTATION: A 44-year-old patient was started on tetracycline therapy for prophylaxis before a periodontal procedure. The patient began having paranoid and psychotic experiences. The patient sought psychiatric medical care and was diagnosed with tetracycline-induced psychosis. He was treated with an antipsychotic drug, which resolved his symptoms.
CONCLUSION: Dental medical histories are a resource that is underused and can often be of value in the continual assessment of drug safety and pharmacovigilance.
© 2013 American Academy of Periodontology.

Entities:  

Keywords:  Drug toxicity; pharmacovigilance; psychotic disorders; safety; tetracycline

Year:  2013        PMID: 26146592      PMCID: PMC4486304          DOI: 10.1902/cap.2012.110007

Source DB:  PubMed          Journal:  Clin Adv Periodontics        ISSN: 2163-0097


  4 in total

1.  [Anaphylactic shock and acute nonallergic reactions following procaine-penicillin].

Authors:  R HOIGNE; K SCHOCH
Journal:  Schweiz Med Wochenschr       Date:  1959-12-26

2.  Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases.

Authors:  Salvatore L Ruggiero; Bhoomi Mehrotra; Tracey J Rosenberg; Stephen L Engroff
Journal:  J Oral Maxillofac Surg       Date:  2004-05       Impact factor: 1.895

3.  Bidirectional transfer between kindling induced by excitatory amino acids and electrical stimulation.

Authors:  N Mori; J A Wada
Journal:  Brain Res       Date:  1987-11-03       Impact factor: 3.252

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.